These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 2982232)
1. The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity. Kloetzer W; Kurzrock R; Smith L; Talpaz M; Spiller M; Gutterman J; Arlinghaus R Virology; 1985 Jan; 140(2):230-8. PubMed ID: 2982232 [TBL] [Abstract][Full Text] [Related]
2. Activation of the c-abl oncogene by viral transduction or chromosomal translocation generates altered c-abl proteins with similar in vitro kinase properties. Davis RL; Konopka JB; Witte ON Mol Cell Biol; 1985 Jan; 5(1):204-13. PubMed ID: 4039028 [TBL] [Abstract][Full Text] [Related]
3. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176 [TBL] [Abstract][Full Text] [Related]
4. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients. Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223 [TBL] [Abstract][Full Text] [Related]
5. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity. Reddy EP; Smith MJ; Srinivasan A Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726 [TBL] [Abstract][Full Text] [Related]
6. Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products. Konopka JB; Witte ON Mol Cell Biol; 1985 Nov; 5(11):3116-23. PubMed ID: 3879812 [TBL] [Abstract][Full Text] [Related]
7. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl. Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879 [TBL] [Abstract][Full Text] [Related]
8. Only site-directed antibodies reactive with the highly conserved src-homologous region of the v-abl protein neutralize kinase activity. Konopka JB; Davis RL; Watanabe SM; Ponticelli AS; Schiff-Maker L; Rosenberg N; Witte ON J Virol; 1984 Jul; 51(1):223-32. PubMed ID: 6610061 [TBL] [Abstract][Full Text] [Related]
9. Activation of the abl oncogene and its involvement in chromosomal translocations in human leukemia. Rosson D; Reddy EP Mutat Res; 1988 May; 195(3):231-43. PubMed ID: 3129652 [TBL] [Abstract][Full Text] [Related]
10. Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells. Naldini L; Stacchini A; Cirillo DM; Aglietta M; Gavosto F; Comoglio PM Mol Cell Biol; 1986 May; 6(5):1803-11. PubMed ID: 2431286 [TBL] [Abstract][Full Text] [Related]
11. Structure and function of the Abelson murine leukemia virus transforming gene. Wang JY; Prywes R; Baltimore D Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691 [TBL] [Abstract][Full Text] [Related]
12. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria. Wang JY; Baltimore D J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223 [TBL] [Abstract][Full Text] [Related]
13. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Konopka JB; Watanabe SM; Singer JW; Collins SJ; Witte ON Proc Natl Acad Sci U S A; 1985 Mar; 82(6):1810-4. PubMed ID: 3856862 [TBL] [Abstract][Full Text] [Related]
14. Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemia. Kurzrock R; Kloetzer WS; Talpaz M; Blick M; Walters R; Arlinghaus RB; Gutterman JU Blood; 1987 Jul; 70(1):233-6. PubMed ID: 2885048 [TBL] [Abstract][Full Text] [Related]
15. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Konopka JB; Watanabe SM; Witte ON Cell; 1984 Jul; 37(3):1035-42. PubMed ID: 6204766 [TBL] [Abstract][Full Text] [Related]
16. The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase. Prywes R; Foulkes JG; Baltimore D J Virol; 1985 Apr; 54(1):114-22. PubMed ID: 2983108 [TBL] [Abstract][Full Text] [Related]
17. A membrane-associated, carbohydrate-modified form of the v-abl protein that cannot be phosphorylated in vivo or in vitro. Watanabe SM; Rosenberg NE; Witte ON J Virol; 1984 Sep; 51(3):620-7. PubMed ID: 6088787 [TBL] [Abstract][Full Text] [Related]
18. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus. Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275 [TBL] [Abstract][Full Text] [Related]
19. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli. Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083 [TBL] [Abstract][Full Text] [Related]
20. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells. Evans CA; Owen-Lynch PJ; Whetton AD; Dive C Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]